Figure 1 presents a lymphonodal biopsy showing a lymphoadenopathy sustained by
Leishmania. The patient, a 55-year-old man, had HIV and was receiving antiretroviral …

Leishmaniasis is considered an emerging opportunistic disease in human
immunodeficiency virus (HIV)–infected patients who have considerably variable clinical …

Coinfection with visceral leishmaniasis and HIV is an emergent problem in several countries
around the world, particularly in Africa, the Indian subcontinent, and the Mediterranean …

Leishmaniasis is a disease caused by protozoa that are transmitted by female sand flies
(Phlebotomus) from either animals to humans (zoonosis) or from humans to humans …

Human visceral leishmaniasis (VL) is a life-threatening disease caused by protozoan
parasites belonging to the Leishmania donovani complex. Atypical cases of leishmaniasis …

Background Visceral leishmaniasis is an important infection in patients infected with human
immunodeficiency virus and living in areas endemic for Leishmania sp. Leishmaniasis …

Background The changes that HIV coinfection can induce in clinical symptoms, response to
treatment and prognosis of visceral Leishmaniasis (VL) are not well known. Method We …

Visceral leishmaniasis is an anthropozoonosis endemic m Spain whose frequency is
increasing among patients infected with HIV [1]. Typical clinical manifestations such as fever …

Visceral leishmaniasis is an anthropozoonosis endemic in the south of France. Its
occurrence among patients infected with human immunodeficiency virus (HIV), in whom it …

Visceral leishmaniasis (VL) has increased as a complicating infection in subjects with
human immunodeficiency virus (HIV) in developing countries. Both infections tend to lower …